|
humans |
77 |
|
female |
42 |
|
male |
41 |
|
animals |
35 |
|
sars-cov-2 |
27 |
|
nasopharyngeal carcinoma |
26 |
|
immunohistochemistry |
25 |
|
adult |
23 |
|
middle aged |
23 |
|
influenza |
22 |
|
covid-19 |
19 |
|
coronavirus |
18 |
|
disease progression |
17 |
|
swine |
17 |
|
transmission |
17 |
|
aged |
16 |
|
respiratory system - virology |
16 |
|
child |
15 |
|
infant |
15 |
|
fatal outcome |
14 |
|
hong kong |
14 |
|
influenza, human - virology |
14 |
|
mers-cov |
14 |
|
promoter hypermethylation |
14 |
|
virus replication |
14 |
|
adolescent |
13 |
|
avian |
13 |
|
cell line, tumor |
13 |
|
conjunctiva - virology |
13 |
|
organ culture techniques |
13 |
|
birds |
12 |
|
bronchi - cytology |
12 |
|
cell cycle |
12 |
|
cells, cultured |
12 |
|
influenza a virus, h1n1 subtype - metabolism |
12 |
|
receptors, cell surface - metabolism |
12 |
|
reverse transcriptase polymerase chain reaction |
12 |
|
sars |
12 |
|
zoonosis |
12 |
|
africa |
11 |
|
biopsy |
11 |
|
down-regulation |
11 |
|
ferrets - virology |
11 |
|
h5n1 |
11 |
|
influenza a virus, h5n1 subtype - metabolism |
11 |
|
mice |
11 |
|
transfection |
11 |
|
acute lung injury |
10 |
|
alveolar epithelial cells |
10 |
|
apoptosis |
10 |
|
carcinoma - metabolism - pathology |
10 |
|
cell differentiation |
10 |
|
chemicals and cas registry numbers |
10 |
|
child, preschool |
10 |
|
conjunctiva |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
cytokines - metabolism |
10 |
|
e-cadherin |
10 |
|
h7n9 |
10 |
|
influenza a virus, h1n1 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h1n2 subtype - genetics - growth & development - pathogenicity |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - metabolism - transmission |
10 |
|
mesenchymal stromal cells |
10 |
|
nasopharyngeal neoplasms - metabolism - pathology |
10 |
|
phylogeny |
10 |
|
reassortant viruses - isolation & purification |
10 |
|
respiratory mucosa - virology |
10 |
|
risk assessment |
10 |
|
rna, messenger - genetics - metabolism |
10 |
|
viral tropism |
10 |
|
virulence |
10 |
|
virus attachment |
10 |
|
alveolar fluid clearance |
9 |
|
cell cycle arrest |
9 |
|
chromosomes, human, pair 14 - genetics |
9 |
|
dna damage |
9 |
|
dna methylation |
9 |
|
gene expression |
9 |
|
genetic predisposition to disease |
9 |
|
in situ hybridization |
9 |
|
microcell-mediated chromosome transfer |
9 |
|
mipol1 |
9 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
9 |
|
neoplasm invasiveness |
9 |
|
pathogenesis |
9 |
|
sars virus - physiology |
9 |
|
severe acute respiratory syndrome |
9 |
|
signal transduction |
9 |
|
tumor cells, cultured |
9 |
|
tumor suppressor proteins - genetics - metabolism |
9 |
|
2009 pandemic h1n1 influenza virus |
8 |
|
autopsy |
8 |
|
bronchi - immunology - pathology |
8 |
|
characterization |
8 |
|
chemokines |
8 |
|
china |
8 |
|
coronaviruses |
8 |
|
cytokines - immunology |
8 |
|
diagnosis, differential |
8 |
|
dogs |
8 |
|
immunity, innate |
8 |
|
influenza a virus, h1n1 subtype - immunology - pathogenicity |
8 |
|
influenza a virus, h5n1 subtype - immunology |
8 |
|
innate host responses |
8 |
|
ip-10 |
8 |
|
medical sciences |
8 |
|
nasopharynx - virology |
8 |
|
neoplasm metastasis |
8 |
|
neoplasm staging |
8 |
|
neuroblastoma - metabolism - pathology |
8 |
|
pathogenicity |
8 |
|
phenotype |
8 |
|
pulmonary alveoli - immunology |
8 |
|
respiratory mucosa - immunology - pathology |
8 |
|
rna, messenger - metabolism |
8 |
|
swine influenza virus |
8 |
|
tropism |
8 |
|
avian influenza |
7 |
|
bronchial tissue |
7 |
|
cell cycle proteins - genetics - metabolism |
7 |
|
cell-mediated immunity |
7 |
|
chfr |
7 |
|
china - epidemiology |
7 |
|
chromatids - genetics - metabolism |
7 |
|
col4a5 |
7 |
|
col4a6 |
7 |
|
copy number variation |
7 |
|
cpg islands - genetics |
7 |
|
dna-directed dna polymerase - genetics - metabolism |
7 |
|
drug resistance, neoplasm |
7 |
|
epigenesis, genetic - genetics |
7 |
|
etiology |
7 |
|
evolution |
7 |
|
gene expression regulation, neoplastic - genetics |
7 |
|
gene expression regulation, viral - physiology |
7 |
|
gene silencing |
7 |
|
gestational age |
7 |
|
gonosomal mosaicism |
7 |
|
hemagglutinin glycoproteins, influenza virus - metabolism |
7 |
|
hemagglutinins - genetics - metabolism |
7 |
|
herpesvirus 4, human - isolation & purification |
7 |
|
histones - metabolism |
7 |
|
infant, newborn |
7 |
|
influenza a |
7 |
|
influenza a virus, h1n1 subtype - enzymology - genetics - physiology |
7 |
|
influenza a virus, h5n1 subtype - classification - genetics |
7 |
|
influenza virus |
7 |
|
isolated diffuse oesophageal leiomyomatosis |
7 |
|
lung - pathology - virology |
7 |
|
mers |
7 |
|
mitosis |
7 |
|
nasal tissue |
7 |
|
nasopharyngeal neoplasms - drug therapy - genetics - metabolism |
7 |
|
nasopharyngeal neoplasms - genetics - pathology |
7 |
|
neoplasm proteins - genetics - metabolism |
7 |
|
neuraminidase - metabolism |
7 |
|
omicron ba.2 |
7 |
|
orthomyxoviridae infections - epidemiology - transmission - virology |
7 |
|
phosphorylation |
7 |
|
promoter regions, genetic - genetics |
7 |
|
proteins - antagonists & inhibitors - genetics - metabolism |
7 |
|
reverse transcriptase polymerase chain reaction - methods |
7 |
|
risk factors |
7 |
|
rna interference |
7 |
|
rna, viral - analysis |
7 |
|
sars cov |
7 |
|
swine, miniature |
7 |
|
tumor necrosis factor-alpha - metabolism |
7 |
|
universal vaccine |
7 |
|
up-regulation |
7 |
|
ventricular remodeling - physiology |
7 |
|
viral genes |
7 |
|
whole exome sequencing |
7 |
|
adherens junctions - metabolism |
6 |
|
aerosols |
6 |
|
airway epithelial cells |
6 |
|
alpha b-crystallin |
6 |
|
anti-angiogenesis |
6 |
|
antibodies, monoclonal - diagnostic use |
6 |
|
biodiversity |
6 |
|
biodiversity conservation |
6 |
|
birds - virology |
6 |
|
blotting, western |
6 |
|
bronchi - pathology |
6 |
|
cadherins - metabolism |
6 |
|
cell movement |
6 |
|
cell nucleus - ultrastructure |
6 |
|
cell proliferation |
6 |
|
cigarette smoking |
6 |
|
combined modality therapy |
6 |
|
conservation of natural resources |
6 |
|
coronavirus - classification - isolation & purification - ultrastructure |
6 |
|
coronavirus infections - diagnosis - transmission - virology |
6 |
|
endocrine glands - metabolism |
6 |
|
epicardial patch |
6 |
|
epstein-barr virus |
6 |
|
ex vivo |
6 |
|
explants |
6 |
|
gene expression regulation, neoplastic |
6 |
|
giant cells - ultrastructure |
6 |
|
herpesvirus 4, human - immunology |
6 |
|
hpai |
6 |
|
influenza a virus, h1n1 subtype - genetics - pathogenicity |
6 |
|
influenza a virus, h3n2 subtype - genetics - pathogenicity |
6 |
|
influenza a virus, h5n1 subtype - classification - genetics - isolation & purification |
6 |
|
influenza in birds - epidemiology - transmission - virology |
6 |
|
influenza, human - epidemiology - transmission - virology |
6 |
|
influenza, human - transmission |
6 |
|
latent transforming growth factor β binding protein 2 (ltbp-2) |
6 |
|
metaplasia |
6 |
|
metastatic growth |
6 |
|
microscopy, electron |
6 |
|
myocardial infarction |
6 |
|
myocardial infarction - pathology - physiopathology - surgery |
6 |
|
nasopharyngeal carcinoma (npc) |
6 |
|
nsp6 |
6 |
|
nucleocapsid proteins - analysis |
6 |
|
opportunistic infections - diagnosis - transmission - virology |
6 |
|
organ size |
6 |
|
orthomyxoviridae infections - transmission |
6 |
|
orthomyxoviridae infections - transmission - veterinary - virology |
6 |
|
owston's civet |
6 |
|
pandemics |
6 |
|
pericardium - pathology - physiopathology |
6 |
|
polymerase chain reaction |
6 |
|
pregnancy |
6 |
|
pregnancy trimester, first |
6 |
|
prosthesis implantation - methods |
6 |
|
radiotherapy |
6 |
|
sars virus - isolation & purification |
6 |
|
sars-cov |
6 |
|
severe acute respiratory syndrome - complications - pathology - virology |
6 |
|
severe acute respiratory syndrome - diagnosis - transmission - virology |
6 |
|
severe acute respiratory syndrome - mortality - physiopathology - virology |
6 |
|
swine - virology |
6 |
|
tumor cell dormancy |
6 |
|
tumor suppression |
6 |
|
tumor suppressor proteins - metabolism |
6 |
|
vascular endothelial growth factor, endocrine-gland-derived - metabolism |
6 |
|
ventricular dysfunction, left - physiopathology - surgery |
6 |
|
ventricular remodeling |
6 |
|
virus cultivation |
6 |
|
virus evolution |
6 |
|
viverrid |
6 |
|
viverridae - anatomy & histology - physiology - virology |
6 |
|
wild species infections |
6 |
|
zoonoses - epidemiology |
6 |
|
β-catenin |
6 |
|
adaptation, biological |
5 |
|
adenoviridae - immunology |
5 |
|
antiviral agents - pharmacology |
5 |
|
bone marrow |
5 |
|
bone marrow transplantation - methods - physiology |
5 |
|
cadherins - genetics - metabolism |
5 |
|
cell count |
5 |
|
cell death - drug effects |
5 |
|
cell polarity |
5 |
|
children |
5 |
|
chronic disease |
5 |
|
clade 2.3.4.4 |
5 |
|
clone cells |
5 |
|
communicable diseases, emerging |
5 |
|
cpg islands |
5 |
|
cyclosporine |
5 |
|
cytokine |
5 |
|
disease outbreaks |
5 |
|
disease reservoirs |
5 |
|
electrophysiologic techniques, cardiac |
5 |
|
endothelial cells - immunology - virology |
5 |
|
epidermal growth factor receptor |
5 |
|
epithelial cells - immunology - virology |
5 |
|
epstein-barr virus infections - immunology - therapy |
5 |
|
epstein-barr virus nuclear antigens - immunology |
5 |
|
ex vivo explants |
5 |
|
ferrets |
5 |
|
flow cytometry |
5 |
|
fluorescent antibody technique |
5 |
|
fomite |
5 |
|
genome, viral |
5 |
|
h7n9 influenza virus |
5 |
|
histology |
5 |
|
hospitalization |
5 |
|
hpai h5nx |
5 |
|
immunization, passive |
5 |
|
influenza a virus - enzymology - genetics |
5 |
|
influenza a virus - genetics - metabolism - physiology |
5 |
|
influenza a virus - physiology |
5 |
|
influenza a virus, h5n1 subtype - drug effects |
5 |
|
influenza b |
5 |
|
influenza in birds - enzymology |
5 |
|
influenza, human - prevention and control - virology |
5 |
|
interferons - metabolism - pharmacology |
5 |
|
ischaemic myocardium |
5 |
|
leukocytes, mononuclear - physiology |
5 |
|
lineage specific |
5 |
|
lung - cytology - drug effects - virology |
5 |
|
lung - drug effects - metabolism - virology |
5 |
|
mammals - virology |
5 |
|
methylation |
5 |
|
microspheres |
5 |
|
middle east respiratory syndrome coronavirus (mers-cov) |
5 |
|
myocardial ischemia - physiopathology |
5 |
|
myocardial revascularization - methods |
5 |
|
myocardium - metabolism |
5 |
|
nasopharyngeal neoplasms - immunology - pathology - therapy - virology |
5 |
|
nasopharyngeal neoplasms - metabolism |
5 |
|
nasopharyngeal neoplasms - pathology - virology |
5 |
|
neovascularization |
5 |
|
neovascularization, physiologic |
5 |
|
neuraminidase inhibitors |
5 |
|
nucleocapsid proteins - genetics - metabolism |
5 |
|
nucleoprotein |
5 |
|
omicron |
5 |
|
paracrine communication |
5 |
|
r292k na mutation |
5 |
|
radiation |
5 |
|
recombinant fusion proteins - pharmacology |
5 |
|
remission induction |
5 |
|
resistance |
5 |
|
rna, neoplasm - metabolism |
5 |
|
sars virus - genetics |
5 |
|
severe acute respiratory syndrome - diagnosis - epidemiology - prevention & control - transmission - virology |
5 |
|
signal transduction - physiology |
5 |
|
stem cells - physiology |
5 |
|
syrian hamsters |
5 |
|
t-lymphocytes, cytotoxic - immunology |
5 |
|
telomerase - metabolism |
5 |
|
tissue tropism |
5 |
|
treatment outcome |
5 |
|
triavalent influenza vaccine |
5 |
|
tumor markers, biological - analysis |
5 |
|
type i interferon |
5 |
|
vaccine effectiveness |
5 |
|
vascular endothelial growth factor a - metabolism |
5 |
|
ventricular function, left |
5 |
|
viral envelope proteins - genetics - metabolism |
5 |
|
viral matrix proteins - genetics - metabolism |
5 |
|
viral matrix proteins - immunology |
5 |
|
viral nonstructural proteins - genetics - metabolism - physiology |
5 |
|
virus assembly |
5 |
|
ablation |
4 |
|
acth syndrome, ectopic - complications - diagnosis |
4 |
|
adjuvants, immunologic - administration and dosage |
4 |
|
adrenocorticotropic hormone - analysis |
4 |
|
amino acid sequence |
4 |
|
antineoplastic agents - pharmacology |
4 |
|
antineoplastic combined chemotherapy protocols - administration & dosage - adverse effects |
4 |
|
antiviral agents - pharmacokinetics - pharmacology |
4 |
|
avian influenza h5n1 virus |
4 |
|
biliary atresia |
4 |
|
biliary epithelial cells |
4 |
|
biological markers |
4 |
|
biopsies |
4 |
|
body temperature |
4 |
|
bone metastases |
4 |
|
bone neoplasms - secondary |
4 |
|
bronchi - metabolism - virology |
4 |
|
bronchial epithelial cells |
4 |
|
carcinoma, squamous cell - drug therapy - mortality - secondary |
4 |
|
carcinoma, squamous cell - radiotherapy - surgery |
4 |
|
carrier proteins - metabolism |
4 |
|
cartilage - cytology - embryology - metabolism |
4 |
|
catheter ablation - methods |
4 |
|
cd56 |
4 |
|
cdc2-cdc28 kinases |
4 |
|
cell cycle - drug effects |
4 |
|
cell division |
4 |
|
cell function |
4 |
|
cell isolation |
4 |
|
cell line |
4 |
|
cell migration |
4 |
|
cell survival - drug effects |
4 |
|
cisplatin |
4 |
|
cisplatin - pharmacology |
4 |
|
collagen - biosynthesis - classification - genetics |
4 |
|
colon carcinoma cells |
4 |
|
colonic neoplasms - pathology |
4 |
|
contraceptive agents, male - toxicity |
4 |
|
coronavirus disease 2019 |
4 |
|
coronavirus infections - diagnosis - mortality |
4 |
|
culture media, serum-free |
4 |
|
cushing syndrome - etiology |
4 |
|
cutaneous fistula - etiology |
4 |
|
cyclin-dependent kinase 2 |
4 |
|
cyclin-dependent kinase 4 |
4 |
|
cyclin-dependent kinase inhibitor p27 |
4 |
|
cyclin-dependent kinases - metabolism |
4 |
|
cytokeratin 7 |
4 |
|
cytology and histology |
4 |
|
diffusion magnetic resonance imaging - methods |
4 |
|
distant metastases |
4 |
|
dna fragmentation - drug effects |
4 |
|
dna-binding proteins - genetics - metabolism |
4 |
|
dose-response relationship, drug |
4 |
|
drug administration schedule |
4 |
|
dti |
4 |
|
ebv |
4 |
|
ectopic acth syndrome |
4 |
|
electrophoresis, agar gel |
4 |
|
embryonic and fetal development - physiology |
4 |
|
enzyme-linked immunosorbent assay |
4 |
|
epithelial cell adhesion molecule |
4 |
|
epithelium - virology |
4 |
|
epitope mapping |
4 |
|
epstein- barr virus |
4 |
|
ex vivo bronchi |
4 |
|
eye tissue |
4 |
|
factor xii deficiency - complications - ethnology |
4 |
|
fetus - metabolism |
4 |
|
fistula |
4 |
|
fludase |
4 |
|
follow-up studies |
4 |
|
gastrointestinal hemorrhage - etiology |
4 |
|
gefitinib |
4 |
|
genes, viral |
4 |
|
gossypol |
4 |
|
gossypol - toxicity |
4 |
|
h5n1 influenza virus |
4 |
|
hae |
4 |
|
hematoma, subdural - etiology |
4 |
|
herpesvirus 4, human - genetics |
4 |
|
herpesvirus 4, human - genetics - immunology - physiology |
4 |
|
heterosubtypic immunity |
4 |
|
histologic remission |
4 |
|
host response |
4 |
|
human |
4 |
|
human respiratory epithelial cell in vitro cultures |
4 |
|
human respiratory organ ex vivo cultures |
4 |
|
id-1 |
4 |
|
il-6 |
4 |
|
il-8 |
4 |
|
in farct size |
4 |
|
infarct location |
4 |
|
influenza a virus, h3n2 subtype - immunology - pathogenicity |
4 |
|
influenza a virus, h5n1 subtype - classification - immunology |
4 |
|
influenza a virus, h5n1 subtype - genetics - pathogenicity |
4 |
|
influenza a virus, h5n1 subtype - immunology - pathogenicity |
4 |
|
influenza in birds - virology |
4 |
|
influenza, human - diagnosis - mortality |
4 |
|
influenza, human - epidemiology - immunology - pathology - physiopathology |
4 |
|
influenza, human - prevention & control |
4 |
|
inhibitor of differentiation protein 1 |
4 |
|
interferons - metabolism |
4 |
|
interleukin-12 - biosynthesis - metabolism |
4 |
|
interleukin-15 - administration and dosage - immunology |
4 |
|
intracellular signaling peptides and proteins |
4 |
|
karyotyping |
4 |
|
kinetics |
4 |
|
laryngeal neoplasms |
4 |
|
laryngeal neoplasms - radiotherapy - surgery |
4 |
|
laryngectomy |
4 |
|
laryngectomy - adverse effects |
4 |
|
lesion |
4 |
|
leukocytes, mononuclear - cytology |
4 |
|
liver fibrosis |
4 |
|
maackia amurensis agglutinin |
4 |
|
macrophages - virology |
4 |
|
maximum tolerated dose |
4 |
|
microwave |
4 |
|
microwaves - therapeutic use |
4 |
|
mitochondria |
4 |
|
molecular sequence data |
4 |
|
monocytes - cytology |
4 |
|
mouse-adaptation |
4 |
|
multiple myeloma - pathology |
4 |
|
muscle, skeletal - pathology - physiology - surgery |
4 |
|
myocardial fiber |
4 |
|
myocardial infarction - pathology |
4 |
|
myocardium infarction |
4 |
|
nasopharyngeal carcinoma cells |
4 |
|
nasopharyngeal neoplasms - complications - diagnosis |
4 |
|
nasopharyngeal neoplasms - drug therapy - mortality - pathology |
4 |
|
nasopharyngeal neoplasms - mortality - pathology - radiotherapy |
4 |
|
neoplasm proteins - metabolism |
4 |
|
neoplasm recurrence, local - drug therapy - mortality - pathology |
4 |
|
neoplasms, multiple primary - diagnosis - pathology - therapy |
4 |
|
neural crest |
4 |
|
neuroectodermal tumors, primitive, peripheral - diagnosis - pathology - therapy |
4 |
|
neurofibromatosis |
4 |
|
neurofibromatosis 1 - diagnosis - pathology - therapy |
4 |
|
next-generation sequencing |
4 |
|
oncology medical sciences |
4 |
|
oral fistula - etiology |
4 |
|
orthomyxoviridae - drug effects |
4 |
|
orthomyxoviridae infections - immunology - physiopathology |
4 |
|
orthomyxoviridae infections - immunology - prevention and control |
4 |
|
osteitis deformans - diagnosis |
4 |
|
osteosclerosis - diagnosis |
4 |
|
pathology |
4 |
|
pharyngeal diseases - etiology |
4 |
|
pharyngectomy |
4 |
|
pharyngocutaneous |
4 |
|
plasmacytoma - complications - pathology |
4 |
|
plasmids |
4 |
|
population surveillance |
4 |
|
primitive neuroectodermal tumor |
4 |
|
prognosis |
4 |
|
proliferation |
4 |
|
protein-serine-threonine kinases - metabolism |
4 |
|
proto-oncogene proteins |
4 |
|
quinazolines - administration & dosage - adverse effects |
4 |
|
radiofrequency |
4 |
|
radiology and nuclear medicine pharmacy and pharmacology biology |
4 |
|
recombinant fusion proteins - pharmacokinetics - pharmacology |
4 |
|
recurrence |
4 |
|
reference values |
4 |
|
remission, spontaneous |
4 |
|
remodeling |
4 |
|
repressor proteins |
4 |
|
respiratory distress syndrome, adult - immunology |
4 |
|
respiratory syncytial virus infections - diagnosis - mortality |
4 |
|
retinoblastoma protein |
4 |
|
retrospective studies |
4 |
|
rna - isolation & purification |
4 |
|
rna, messenger - biosynthesis - metabolism |
4 |
|
sambucus nigra agglutnin |
4 |
|
sars virus - genetics - metabolism |
4 |
|
sciences: comprehensive works |
4 |
|
sialic acid receptors |
4 |
|
stomach neoplasms - complications - pathology |
4 |
|
survival analysis |
4 |
|
time factors |
4 |
|
tissue distribution |
4 |
|
tomography, x-ray computed |
4 |
|
transcription factors - genetics - metabolism |
4 |
|
type ii pneumocytes |
4 |
|
type-i-like pneumocytes |
4 |
|
universal vaccines |
4 |
|
vaccinia virus - genetics - immunology |
4 |
|
ventricular dysfunction, left - pathology |
4 |
|
viral infection |
4 |
|
viral load |
4 |
|
viral matrix proteins - analysis |
4 |
|
viral nonstructural proteins - genetics |
4 |
|
acute disease |
3 |
|
adaptor proteins, vesicular transport - metabolism |
3 |
|
adenoma - blood - complications - pathology |
3 |
|
adoptive cell therapy |
3 |
|
adrenocorticotropic hormone - blood |
3 |
|
agammaglobulinemia |
3 |
|
alternative splicing |
3 |
|
amino acid metabolism, inborn errors - blood - immunology |
3 |
|
amino acids - analysis |
3 |
|
analgesia intra-articular |
3 |
|
analgesics non-opioid ketorolac |
3 |
|
angiogenesis |
3 |
|
anisotropy |
3 |
|
antibodies, monoclonal |
3 |
|
antibodies, viral - isolation & purification |
3 |
|
antigens, cd56 - metabolism |
3 |
|
antigens, viral - analysis |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
antisense elements (genetics) |
3 |
|
apoptosis - drug effects - genetics |
3 |
|
astrocytes - cytology - immunology - virology |
3 |
|
avian h5n1 virus |
3 |
|
barf1 |
3 |
|
base sequence |
3 |
|
beta-galactosidase - metabolism |
3 |
|
bone and bones - embryology |
3 |
|
borderzone |
3 |
|
brain neoplasms - immunology - pathology - secondary |
3 |
|
bronchi - metabolism |
3 |
|
cancer vaccine |
3 |
|
carcinoma |
3 |
|
carcinoma - enzymology - pathology |
3 |
|
carcinoma - pathology - virology |
3 |
|
carcinoma, hepatocellular - blood - complications - pathology |
3 |
|
carcinoma, squamous cell - pathology - virology |
3 |
|
carrier proteins - genetics - physiology |
3 |
|
cartilage - embryology |
3 |
|
case-control studies |
3 |
|
cell aging - drug effects |
3 |
|
cell cycle - drug effects - physiology |
3 |
|
cell cycle - radiation effects |
3 |
|
cell division - drug effects |
3 |
|
cell division - drug effects - physiology |
3 |
|
cell proliferation - drug effects |
3 |
|
cell survival - drug effects - physiology |
3 |
|
cellimmuno |
3 |
|
cervical vertebrae - abnormalities - ultrasonography |
3 |
|
checkpoint inhibitors |
3 |
|
chemokine ccl2 - biosynthesis |
3 |
|
children, chinese |
3 |
|
chromatography, gas |
3 |
|
chromatography, high pressure liquid |
3 |
|
cisplatin - toxicity |
3 |
|
codon - genetics |
3 |
|
collagen - genetics |
3 |
|
culture media, conditioned - chemistry |
3 |
|
cyclin-dependent kinase inhibitor p16 |
3 |
|
cyclin-dependent kinases - antagonists & inhibitors |
3 |
|
cyclooxygenase 2 - biosynthesis |
3 |
|
cytopathogenic effect, viral |
3 |
|
cytotoxic t cells |
3 |
|
dengue virus - classification - genetics - physiology |
3 |
|
diaphragmatic hernia |
3 |
|
diffusion magnetic resonance imaging |
3 |
|
diffusion tensor imaging |
3 |
|
disease models, animal |
3 |
|
dna, viral - isolation & purification |
3 |
|
dose-response relationship, radiation |
3 |
|
dysostoses - ultrasonography |
3 |
|
ebv expression |
3 |
|
embryo, mammalian - metabolism |
3 |
|
embryonic and fetal development |
3 |
|
enterocolitis, necrotizing - genetics - metabolism - pathology |
3 |
|
enzyme activation |
3 |
|
enzyme induction - radiation effects |
3 |
|
epstein-barr virus infections - complications - diagnosis |
3 |
|
ex vivo human bronchus culture |
3 |
|
ex vivo lung culture |
3 |
|
fetal diseases - ultrasonography |
3 |
|
fiber architecture |
3 |
|
fluorescent antibody technique, direct - methods |
3 |
|
fluorouracil - toxicity |
3 |
|
g1 phase - radiation effects |
3 |
|
galactose - analogs & derivatives - biosynthesis |
3 |
|
gamma rays |
3 |
|
gastric cancer |
3 |
|
gastric dilatation - ultrasonography |
3 |
|
gene expression regulation, neoplastic - drug effects - genetics |
3 |
|
gene transfer techniques |
3 |
|
genes, tumor suppressor |
3 |
|
genetic vectors - genetics |
3 |
|
hemagglutinin glycoproteins, influenza virus - chemistry - genetics - metabolism |
3 |
|
hernia, diaphragmatic - ultrasonography |
3 |
|
herpesviridae infections |
3 |
|
herpesvirus 4, human |
3 |
|
herpesvirus 4, human - genetics - immunology - isolation & purification |
3 |
|
hirsutism - blood - etiology |
3 |
|
hodgkin's disease |
3 |
|
host-pathogen interactions |
3 |
|
human seasonal h1n1 virus |
3 |
|
human α1(ii) collagen mrna |
3 |
|
humdisease |
3 |
|
hydrocortisone - blood |
3 |
|
immunodeficiency |
3 |
|
immunologic deficiency syndromes - complications - immunology |
3 |
|
immunotherapy |
3 |
|
inborn error of immunity |
3 |
|
influenza a virus |
3 |
|
influenza a virus - genetics - metabolism |
3 |
|
influenza a virus - isolation & purification |
3 |
|
influenza a virus, h1n1 subtype - physiology |
3 |
|
influenza a virus, h3n2 subtype - metabolism |
3 |
|
influenza a virus, h5n1 subtype |
3 |
|
influenza a virus, h5n1 subtype - pathogenicity |
3 |
|
influenza a virus, h5n1 subtype - physiology |
3 |
|
influenza, human - metabolism |
3 |
|
influenza, human - metabolism - virology |
3 |
|
interleukin-6 - biosynthesis - genetics |
3 |
|
interleukin-6 - blood |
3 |
|
interleukin-6 - metabolism |
3 |
|
interleukin-8 - biosynthesis - genetics |
3 |
|
interleukin-8 - blood |
3 |
|
jarcho-levin syndrome |
3 |
|
jejunal neoplasms - diagnosis - immunology - pathology |
3 |
|
keywords: liver cell adenoma, bile pigment, hirsutism, child |
3 |
|
learning objectives |
3 |
|
liver neoplasms - blood - complications - pathology |
3 |
|
lung |
3 |
|
lymphangioma |
3 |
|
lymphangioma - epidemiology - pathology - surgery |
3 |
|
lymphocyte subsets - immunology |
3 |
|
lymphoma, t-cell, peripheral - diagnosis - immunology - pathology |
3 |
|
macrophage migration-inhibitory factors - blood - genetics - metabolism |
3 |
|
macrophage migration-inhibitory factors - metabolism |
3 |
|
macrophages - cytology - metabolism |
3 |
|
mapk |
3 |
|
methylmalonic acid - blood |
3 |
|
methylmalonic acidaemia |
3 |
|
mice, inbred c57bl |
3 |
|
microvascular endothelial cells |
3 |
|
mif |
3 |
|
mitogen-activated protein kinases - antagonists & inhibitors - metabolism |
3 |
|
models, molecular |
3 |
|
n-myc |
3 |
|
nadph oxidase - metabolism |
3 |
|
nasopharjngeal neoplasms |
3 |
|
nasopharyngeal aspirates (npa) |
3 |
|
nasopharyngeal flocked swabs (npfs) |
3 |
|
nasopharyngeal neoplasms |
3 |
|
nasopharyngeal neoplasms - chemistry - diagnosis - radiotherapy |
3 |
|
nasopharyngeal neoplasms - enzymology |
3 |
|
nasopharyngeal neoplasms - enzymology - pathology |
3 |
|
nasopharyngeal neoplasms - pathology - radiotherapy |
3 |
|
nasopharyngeal neoplasms - virology |
3 |
|
nec |
3 |
|
neoplasm recurrence, local - virology |
3 |
|
neoplasm transplantation |
3 |
|
neuraminidase |
3 |
|
neuraminidase - chemistry |
3 |
|
neuroblastoma |
3 |
|
neurodegenerative disease |
3 |
|
neuroinflammation |
3 |
|
neurons - cytology - immunology - virology |
3 |
|
nf-kappa b - metabolism |
3 |
|
non-chondrogenic expression |
3 |
|
npc differentiation |
3 |
|
nuclear magnetic resonance |
3 |
|
oligonucleotide array sequence analysis |
3 |
|
oligonucleotide probes - genetics |
3 |
|
orthomyxoviridae infections - metabolism |
3 |
|
oxidative stress |
3 |
|
paclitaxel - pharmacology |
3 |
|
pancreas |
3 |
|
pancreas - pathology |
3 |
|
pancreatic neoplasms - epidemiology - pathology - surgery |
3 |
|
pandemic h1n1pdm virus |
3 |
|
parainfluenza virus 1, human - isolation & purification |
3 |
|
parainfluenza virus 2, human - isolation & purification |
3 |
|
parainfluenza virus 3, human - isolation & purification |
3 |
|
paraneoplastic syndromes - diagnosis - etiology |
3 |
|
pbl |
3 |
|
phospholipids - metabolism |
3 |
|
predictive value of tests |
3 |
|
procollagen - genetics |
3 |
|
protein precursors - genetics |
3 |
|
proto-oncogene proteins c-myc - biosynthesis - genetics |
3 |
|
questionaire |
3 |
|
rapid diagnosis |
3 |
|
rat |
3 |
|
receptor interaction |
3 |
|
receptors, antigen, t-cell, gamma-delta - metabolism |
3 |
|
receptors, cell surface - chemistry - genetics - metabolism |
3 |
|
receptors, virus - biosynthesis |
3 |
|
receptors, virus - chemistry - genetics - metabolism |
3 |
|
receptors, virus - chemistry - metabolism |
3 |
|
recombinant fusion proteins - chemistry - pharmacology |
3 |
|
recombinant proteins - metabolism |
3 |
|
respiratory distress syndrome, adult - metabolism |
3 |
|
respiratory mucosa - cytology - metabolism |
3 |
|
respiratory syncytial viruses - isolation & purification |
3 |
|
respiratory tract infections - virology |
3 |
|
respiratory viruses |
3 |
|
ribs - abnormalities - ultrasonography |
3 |
|
rna, messenger - biosynthesis |
3 |
|
rna, messenger - genetics |
3 |
|
sars virus - metabolism |
3 |
|
saturation transfer difference |
3 |
|
scoliosis - ultrasonography |
3 |
|
sensitivity and specificity |
3 |
|
sepsis - complications |
3 |
|
serology |
3 |
|
severe acute respiratory syndrome (sars) |
3 |
|
severe acute respiratory syndrome - metabolism |
3 |
|
sialoglycoproteins - chemistry - metabolism |
3 |
|
specimen handling - methods |
3 |
|
spine - abnormalities - ultrasonography |
3 |
|
spondylocostal dysostosis |
3 |
|
stomach |
3 |
|
stomach neoplasms - drug therapy - genetics - metabolism |
3 |
|
telomerase |
3 |
|
telomerase activation |
3 |
|
thoracic vertebrae - abnormalities - ultrasonography |
3 |
|
toll-like receptor 4 - metabolism |
3 |
|
transplantation, heterologous |
3 |
|
tumor burden |
3 |
|
tumor cells, cultured - enzymology - radiation effects |
3 |
|
tumor marker |
3 |
|
tumor necrosis factor-alpha - biosynthesis - genetics |
3 |
|
tumor stem cell assay |
3 |
|
tumor suppressor protein p53 - drug effects - metabolism - physiology |
3 |
|
tumor virus infections |
3 |
|
ultrasonography, prenatal |
3 |
|
ultrasound |
3 |
|
up-regulation - genetics |
3 |
|
vascular endothelial growth factor a - biosynthesis - genetics |
3 |
|
viral proteins - genetics - metabolism |
3 |
|
viral proteins - genetics - pharmacology - physiology |
3 |
|
virion - metabolism |
3 |
|
virus assembly - physiology |
3 |
|
virus diseases - virology |
3 |
|
virus latency |
3 |
|
viruses - genetics - isolation & purification |
3 |
|
x-linked lymphoproliferative disease type 1 (xlp1) |
3 |
|
xenograft |
3 |
|
actuarial analysis |
2 |
|
acute kidney injury - etiology |
2 |
|
aged, 80 and over |
2 |
|
antibodies, monoclonal - immunology |
2 |
|
antibodies, viral - immunology |
2 |
|
antibody specificity |
2 |
|
antifungal agents - therapeutic use |
2 |
|
antigens, viral - immunology |
2 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
2 |
|
barna, messenger - metabolism |
2 |
|
bile duct neoplasms - mortality - pathology - ultrastructure |
2 |
|
bile ducts, intrahepatic - pathology |
2 |
|
brachytherapy |
2 |
|
brain tumour |
2 |
|
candidiasis - diagnosis - microbiology |
2 |
|
carbohydrates |
2 |
|
carboxypeptidases - metabolism |
2 |
|
carcinoma - diagnosis - therapy |
2 |
|
carcinoma - microbiology - pathology |
2 |
|
carcinoma - mortality - pathology - radiotherapy - therapy |
2 |
|
carcinoma in situ - diagnosis - therapy - virology |
2 |
|
carcinoma, hepatocellular - mortality - pathology - ultrastructure |
2 |
|
carcinoma, papillary - complications |
2 |
|
carcinoma, squamous cell - microbiology - pathology |
2 |
|
carcinoma, transitional cell - complications |
2 |
|
cell line, transformed |
2 |
|
cell transformation, neoplastic - pathology - radiation effects |
2 |
|
cholangiocarcinoma - mortality - pathology - ultrastructure |
2 |
|
chromosomes, human, pair 3 |
2 |
|
cisplatin - administration & dosage |
2 |
|
clinicopathological features |
2 |
|
combined hepatocellular- cholangiocarcinoma |
2 |
|
cranial fossa, posterior - surgery |
2 |
|
cranial irradiation - adverse effects |
2 |
|
cross infection - diagnosis - microbiology |
2 |
|
cross infection - microbiology - transmission |
2 |
|
dna primers - chemistry |
2 |
|
dna, viral - analysis - isolation & purification |
2 |
|
ear, middle - pathology - radiography - surgery |
2 |
|
endoscopy - methods |
2 |
|
epirubicin - administration & dosage |
2 |
|
epstein-barr virus (ebv) |
2 |
|
epstein-barr virus infections - virology |
2 |
|
fiber optic technology |
2 |
|
fungemia - diagnosis - microbiology |
2 |
|
gene expression regulation, developmental |
2 |
|
haemangiopericytoma |
2 |
|
hemagglutinin |
2 |
|
hemagglutinin glycoproteins, influenza virus - biosynthesis - genetics - metabolism |
2 |
|
hemagglutinin glycoproteins, influenza virus - chemistry |
2 |
|
hemangiopericytoma - pathology - radiotherapy - surgery |
2 |
|
herpesviridae infections - pathology |
2 |
|
histological techniques |
2 |
|
hodgkin disease - virology |
2 |
|
induction chemotherapy |
2 |
|
infant, premature |
2 |
|
infant, premature, diseases - diagnosis - microbiology |
2 |
|
influenza a virus - chemistry - classification |
2 |
|
influenza a virus, h1n1 subtype - genetics - physiology - ultrastructure |
2 |
|
influenza a virus, h5n1 subtype - genetics - pathogenicity - physiology |
2 |
|
influenza a virus, h5n1 subtype - genetics - physiology - ultrastructure |
2 |
|
influenza in birds - blood - diagnosis - virology |
2 |
|
influenza, human - blood - diagnosis - virology |
2 |
|
influenza, human - diagnosis - etiology - physiopathology |
2 |
|
influenza, human - pathology - virology |
2 |
|
intestines - virology |
2 |
|
intranasal |
2 |
|
intraperitoneal |
2 |
|
intravascular lymphomatosis |
2 |
|
iridium radioisotopes - therapeutic use |
2 |
|
laboratory diagnosis |
2 |
|
latent membrane protein (lmp 1) |
2 |
|
lentivirus - genetics - pathogenicity - physiology |
2 |
|
liver neoplasms - mortality - pathology - ultrastructure |
2 |
|
lmp1 |
2 |
|
lps |
2 |
|
luciferases - genetics |
2 |
|
lymphatic metastasis |
2 |
|
lymphocytes - virology |
2 |
|
lymphoma, large b-cell, diffuse - pathology - virology |
2 |
|
lymphoma, t-cell - pathology - virology |
2 |
|
lymphoma, t-cell, peripheral - virology |
2 |
|
magnetic resonance spectroscopy - methods - standards |
2 |
|
malassezia - isolation & purification |
2 |
|
meningeal neoplasms - pathology - radiotherapy - surgery |
2 |
|
monoclonal antibodies |
2 |
|
mycoses - microbiology - transmission |
2 |
|
n-acetylneuraminic acid - metabolism |
2 |
|
nasopharyngeal neoplasms - diagnosis - therapy |
2 |
|
nasopharyngeal neoplasms - diagnosis - therapy - virology |
2 |
|
nasopharyngeal neoplasms - drug therapy - metabolism - pathology - radiotherapy |
2 |
|
nasopharyngeal neoplasms - mortality - pathology - radiotherapy - therapy |
2 |
|
nasopharynx - pathology |
2 |
|
neck |
2 |
|
neck dissection |
2 |
|
neoplasm recurrence, local |
2 |
|
neoplasm recurrence, local - pathology - surgery |
2 |
|
neoplasms, multiple primary - mortality - pathology - ultrastructure |
2 |
|
neoplasms, radiation-induced - pathology |
2 |
|
neuraminidase - chemistry - metabolism |
2 |
|
neuraminidase - genetics - physiology |
2 |
|
neutralization tests - methods |
2 |
|
nmr spectroscopy |
2 |
|
npc |
2 |
|
nuclear magnetic resonance, biomolecular |
2 |
|
nucleic acid amplification techniques |
2 |
|
oncogene proteins, viral - analysis - chemistry - genetics - immunology |
2 |
|
organ injury |
2 |
|
orthomyxoviridae - chemistry - enzymology |
2 |
|
oseltamivir - pharmacology |
2 |
|
parenteral nutrition, total - adverse effects |
2 |
|
particle size |
2 |
|
peptidyl-dipeptidase a - metabolism |
2 |
|
promoter regions (genetics) |
2 |
|
proportional hazards models |
2 |
|
prospective studies |
2 |
|
proto-oncogene proteins - genetics |
2 |
|
pseudotyped lentiviral particles |
2 |
|
pulmonary alveoli - metabolism |
2 |
|
radiosurgery |
2 |
|
radiotherapy dosage |
2 |
|
radiotherapy, adjuvant |
2 |
|
receptor, epidermal growth factor - metabolism |
2 |
|
receptors, cell surface - chemistry |
2 |
|
reoperation |
2 |
|
respiratory distress syndrome, adult - enzymology - etiology |
2 |
|
rhabdomyosarcoma |
2 |
|
rhabdomyosarcoma - pathology |
2 |
|
sars coronavirus |
2 |
|
sars virus - isolation & purification - pathogenicity |
2 |
|
sepsis |
2 |
|
sequence deletion |
2 |
|
serodiagnostic |
2 |
|
serologic tests - methods |
2 |
|
severe acute respiratory syndrome - complications - enzymology |
2 |
|
severe acute respiratory syndrome - diagnosis - etiology - physiopathology |
2 |
|
severe acute respiratory syndrome - pathology - virology |
2 |
|
sialic acid |
2 |
|
sialic acids |
2 |
|
species specificity |
2 |
|
survival |
2 |
|
survival rate |
2 |
|
t-cell |
2 |
|
tonsil neoplasm |
2 |
|
tonsillar neoplasms - microbiology - pathology |
2 |
|
transformation |
2 |
|
tumor suppressor protein p53 - metabolism |
2 |
|
tumor virus infections - pathology |
2 |
|
urinary bladder neoplasms - complications |
2 |
|
viral matrix proteins - analysis - chemistry - genetics - immunology |
2 |
|
viral proteins - genetics - physiology |
2 |
|
virion - genetics - pathogenicity - physiology |
2 |
|
virus assembly - genetics - physiology |
2 |
|
virus replication - physiology |
2 |
|
viruses |
2 |
|
放射治療 |
2 |
|
香港大å¸é†«å¸é™¢ |
2 |
|
鼻咽癌治療 |
2 |
|
鼻咽癌病人 |
2 |
|
鼻咽部 |
2 |
|
30-bp deletion |
1 |
|
a/hong kong/1/68 |
1 |
|
adenocarcinoma |
1 |
|
adenocarcinoma - etiology - pathology |
1 |
|
alkaline phosphatase - metabolism |
1 |
|
alleles |
1 |
|
analytic test validation |
1 |
|
anatomical pathology |
1 |
|
anatomy - methods |
1 |
|
antibodies, viral - blood |
1 |
|
antigen presentation - physiology |
1 |
|
antigens, cd - analysis |
1 |
|
antigens, cd63 |
1 |
|
antiviral agents - pharmacology - therapeutic use |
1 |
|
atp-binding cassette transporters - metabolism |
1 |
|
bacterial adhesion |
1 |
|
bamhi-f region |
1 |
|
bcl-2 |
1 |
|
bhrf1 |
1 |
|
bladder |
1 |
|
bladder carcinoma |
1 |
|
blood donors |
1 |
|
blood-borne viruses |
1 |
|
blotting, southern |
1 |
|
brain neoplasms - drug therapy - enzymology |
1 |
|
breast neoplasms - chemistry - diagnosis - metabolism |
1 |
|
burkitt lymphoma - immunology |
1 |
|
burkitt lymphoma - virology |
1 |
|
carcinoma - classification - virology |
1 |
|
carcinoma - enzymology - pathology - virology |
1 |
|
carcinoma - genetics - immunology - virology |
1 |
|
carcinoma - immunology - metabolism - pathology |
1 |
|
carcinoma - immunology - pathology |
1 |
|
carcinoma - pathology - radiotherapy |
1 |
|
carcinoma - virology |
1 |
|
carcinoma in situ - metabolism - pathology - virology |
1 |
|
carcinoma in situ - pathology |
1 |
|
carcinoma, squamous cell - chemistry - complications - virology |
1 |
|
carcinoma, squamous cell - epidemiology - virology |
1 |
|
carcinoma, squamous cell - genetics - immunology - virology |
1 |
|
carcinoma, squamous cell - immunology - pathology |
1 |
|
carcinoma, squamous cell - metabolism |
1 |
|
carcinoma, squamous cell - metabolism - pathology - virology |
1 |
|
carcinoma, squamous cell - virology |
1 |
|
carcinoma-in-situ-pathology |
1 |
|
carrier proteins - genetics |
1 |
|
cell adhesion molecules - analysis |
1 |
|
cell transformation, neoplastic - pathology |
1 |
|
cell transformation, viral |
1 |
|
central nervous system |
1 |
|
chemokine ccl17 |
1 |
|
chemokines, cc - analysis - genetics |
1 |
|
cloning, molecular |
1 |
|
clothing |
1 |
|
competitive polymerase chain reaction |
1 |
|
coronary vessels - pathology |
1 |
|
cyclin-dependent kinase inhibitor p16 - metabolism |
1 |
|
cytokines - genetics |
1 |
|
cytotoxic t lymphocyte |
1 |
|
deoxyribonuclease bamhi - genetics |
1 |
|
diabetes, gestational - complications |
1 |
|
diagnosis |
1 |
|
disease outbreaks - prevention & control |
1 |
|
diverticulum |
1 |
|
diverticulum - pathology |
1 |
|
dna replication |
1 |
|
dna, viral |
1 |
|
dna, viral - analysis |
1 |
|
dna, viral - analysis - genetics |
1 |
|
dna, viral - genetics |
1 |
|
dna-binding proteins |
1 |
|
dna-binding proteins - metabolism |
1 |
|
drugs, chinese herbal - adverse effects |
1 |
|
ebna2 |
1 |
|
england - epidemiology |
1 |
|
epithelium - pathology - virology |
1 |
|
epitope |
1 |
|
epitopes - immunology |
1 |
|
epitopes, t-lymphocyte - analysis - chemistry |
1 |
|
epstein-barr virus infections - genetics |
1 |
|
epstein-barr virus infections - genetics - immunology |
1 |
|
epstein-barr virus nuclear antigen 1 |
1 |
|
epstein-barr virus nuclear antigens - genetics |
1 |
|
evolution, molecular |
1 |
|
fatal cases |
1 |
|
fibrosis - pathology |
1 |
|
foreign bodies |
1 |
|
gene deletion |
1 |
|
gene expression regulation, viral |
1 |
|
genetic variation |
1 |
|
genitalia, female - abnormalities |
1 |
|
germany - epidemiology |
1 |
|
hand, foot and mouth disease |
1 |
|
heart failure - pathology |
1 |
|
hemorrhage - pathology |
1 |
|
hemorrhagic myocarditis |
1 |
|
hepacivirus - isolation & purification |
1 |
|
hepatitis b - epidemiology |
1 |
|
hepatitis b surface antigens - analysis |
1 |
|
hepatitis c - epidemiology |
1 |
|
hepatitis c antibodies - blood |
1 |
|
hepatitis viruses |
1 |
|
herpesviridae infections - complications - diagnosis - genetics |
1 |
|
herpesviridae infections - complications - epidemiology |
1 |
|
herpesviridae infections - enzymology - pathology - virology |
1 |
|
herpesviridae infections - metabolism - pathology |
1 |
|
herpesvirus 4, human - enzymology - isolation & purification |
1 |
|
herpesvirus 4, human - genetics - immunology |
1 |
|
herpesvirus 4, human - genetics - isolation & purification |
1 |
|
herpesvirus 4, human - genetics - physiology |
1 |
|
histocompatibility antigens class i - immunology |
1 |
|
histocytochemistry |
1 |
|
hiv antibodies - blood |
1 |
|
hiv infections - epidemiology |
1 |
|
hiv seroprevalence |
1 |
|
hiv-1 - classification - genetics - immunology - isolation & purification |
1 |
|
hiv-1 prevalence |
1 |
|
hla restriction |
1 |
|
hla-a2 antigen - genetics - immunology - metabolism |
1 |
|
hodgkin disease - genetics - immunology - virology |
1 |
|
hong kong - epidemiology |
1 |
|
htlv-i antibodies - blood |
1 |
|
htlv-i infections - epidemiology |
1 |
|
human enterovirus a71 |
1 |
|
hyperacute rejection |
1 |
|
il-10 |
1 |
|
immune system - physiology |
1 |
|
immunoenzyme techniques |
1 |
|
immunohistochemistry - methods |
1 |
|
in situ hybridization - methods |
1 |
|
in-situ carcinoma |
1 |
|
infectious mononucleosis - virology |
1 |
|
innate immunity |
1 |
|
integrins |
1 |
|
intercellular adhesion molecule-1 |
1 |
|
interleukin-10 - analysis - genetics |
1 |
|
interleukin-6 - analysis - genetics |
1 |
|
interleukin-8 - analysis - genetics |
1 |
|
jun/ap-1 |
1 |
|
latent membrane protein 1 |
1 |
|
lectin |
1 |
|
lectins - metabolism |
1 |
|
local recurrence |
1 |
|
luciferases - metabolism |
1 |
|
lung - pathology |
1 |
|
lupus erythematosus |
1 |
|
lupus erythematosus, systemic - pathology |
1 |
|
lymphocyte activation |
1 |
|
lymphoepithelioma |
1 |
|
lymphoepithelioma-like carcinoma |
1 |
|
lymphoid stroma |
1 |
|
lymphoid tissue - pathology - physiopathology |
1 |
|
lymphoma - genetics - virology |
1 |
|
lymphoproliferative disorders - drug therapy - enzymology |
1 |
|
malawi - epidemiology |
1 |
|
melanin |
1 |
|
melanins - analysis |
1 |
|
membrane proteins |
1 |
|
metaplasia - pathology - surgery |
1 |
|
mice, nude |
1 |
|
micrornas - biosynthesis - genetics - isolation & purification |
1 |
|
mitogens - pharmacology |
1 |
|
mucin |
1 |
|
myocarditis - pathology |
1 |
|
myocardium - pathology |
1 |
|
n-acetylneuraminic acid - analysis |
1 |
|
nasal mucosa - pathology |
1 |
|
nasopharyngeal neoplasms - chemistry - complications - virology |
1 |
|
nasopharyngeal neoplasms - chemistry - ethnology - virology |
1 |
|
nasopharyngeal neoplasms - diagnosis - virology |
1 |
|
nasopharyngeal neoplasms - enzymology - pathology - virology |
1 |
|
nasopharyngeal neoplasms - epidemiology - virology |
1 |
|
nasopharyngeal neoplasms - genetics - immunology - virology |
1 |
|
nasopharyngeal neoplasms - immunology - metabolism - pathology |
1 |
|
nasopharyngeal neoplasms - immunology - pathology |
1 |
|
nasopharyngeal neoplasms - metabolism - pathology - virology |
1 |
|
nasopharyngeal neoplasms - pathology |
1 |
|
nasopharyngeal-neoplasms-pathology |
1 |
|
nasopharynx |
1 |
|
nasopharynx - chemistry - pathology |
1 |
|
nasopharynx - pathology - virology |
1 |
|
neoplasm recurrence, local - pathology |
1 |
|
neoplasms - chemistry - diagnosis - metabolism |
1 |
|
neoplasms, experimental - immunology - virology |
1 |
|
neoplasms, glandular and epithelial - drug therapy - enzymology |
1 |
|
neuraminidase - pharmacology - therapeutic use |
1 |
|
nfkb |
1 |
|
nuclear proteins |
1 |
|
nucleocapsid proteins - metabolism |
1 |
|
oncocytic metaplasia |
1 |
|
oncogene proteins, viral - immunology |
1 |
|
oral hairy leukoplakia |
1 |
|
orthomyxoviridae - growth and development |
1 |
|
p14(arf) |
1 |
|
p53 |
1 |
|
p63 |
1 |
|
parotid neoplasms - chemistry - ethnology - virology |
1 |
|
pathology - methods |
1 |
|
peptide fragments - immunology - metabolism |
1 |
|
perineum - abnormalities |
1 |
|
phosphoproteins - genetics - metabolism |
1 |
|
pigs |
1 |
|
platelet membrane glycoproteins - analysis |
1 |
|
pneumococcal infections |
1 |
|
post-transplant lymphoproliferative disorder |
1 |
|
precancerous conditions |
1 |
|
prevalence |
1 |
|
protein binding |
1 |
|
protein binding - immunology |
1 |
|
protein isoforms - genetics - metabolism |
1 |
|
protein structure, tertiary |
1 |
|
proteins - genetics |
1 |
|
proteomics |
1 |
|
proto-oncogene proteins - biosynthesis |
1 |
|
proto-oncogene proteins c-mdm2 |
1 |
|
pulmonary |
1 |
|
pulmonary edema - pathology |
1 |
|
pyrophosphatases - antagonists & inhibitors - metabolism |
1 |
|
pyrophosphatases - immunology |
1 |
|
rats |
1 |
|
reagent kits, diagnostic |
1 |
|
receptor specificity |
1 |
|
receptors, virus - analysis |
1 |
|
recombinant proteins - pharmacology - therapeutic use |
1 |
|
reed-sternberg cells - immunology |
1 |
|
reproducibility of results |
1 |
|
respiratory explants |
1 |
|
respiratory mucosa - chemistry |
1 |
|
respiratory system - chemistry - virology |
1 |
|
retinoblastoma protein - metabolism |
1 |
|
ribosomal proteins |
1 |
|
rig-i |
1 |
|
rna, messenger - analysis |
1 |
|
rna, viral - analysis - genetics |
1 |
|
rna, viral - biosynthesis - genetics - isolation & purification |
1 |
|
rna, viral - blood |
1 |
|
rna, viral - metabolism |
1 |
|
rna-binding proteins - genetics |
1 |
|
russia - epidemiology |
1 |
|
saliva - chemistry |
1 |
|
selection (genetics) |
1 |
|
sequence analysis, dna |
1 |
|
sequence homology, nucleic acid |
1 |
|
smad3 protein - metabolism |
1 |
|
smad4 protein - metabolism |
1 |
|
squamous cell carcinoma |
1 |
|
streptococcus pneumoniae - physiology |
1 |
|
stromal cells - virology |
1 |
|
t-lymphocytes, cytotoxic - immunology - metabolism |
1 |
|
t-lymphocytes, cytotoxic - immunology - virology |
1 |
|
tarc |
1 |
|
trans-activators |
1 |
|
trans-activators - metabolism |
1 |
|
transcription factors |
1 |
|
transforming growth factor beta - metabolism |
1 |
|
tumor markers, biological - analysis - metabolism |
1 |
|
tumor suppressor protein p14arf |
1 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
1 |
|
tumor suppressor proteins |
1 |
|
tumor virus infections - complications - diagnosis - genetics |
1 |
|
tumor virus infections - complications - epidemiology |
1 |
|
tumor virus infections - enzymology - pathology - virology |
1 |
|
tumor virus infections - immunology |
1 |
|
tumor virus infections - metabolism - pathology |
1 |
|
undifferentiated nusopharyngeal carcinoma |
1 |
|
urinary bladder neoplasms - chemistry - complications - virology |
1 |
|
urinary bladder neoplasms - etiology - pathology |
1 |
|
vagina |
1 |
|
vascular cell adhesion molecule-1 |
1 |
|
viral load - methods |
1 |
|
viral matrix proteins - analysis - blood - pharmacology |
1 |
|
viral matrix proteins - genetics |
1 |
|
viral matrix proteins - genetics - isolation & purification |
1 |
|
viral matrix proteins - immunology - metabolism |
1 |
|
viral matrix proteins - metabolism |
1 |
|
viral proteins |
1 |
|
viral proteins - analysis - blood - pharmacology |
1 |
|
viral proteins - immunology |
1 |
|
viral proteins - metabolism |
1 |
